Studies show that IBS patients have lower levels of 25(OH)D compared to non-IBS controls, as well as reduced expression of TPH1, the enzyme responsible for the rate-limiting step in serotonin synthesis in gut enterochromaffin cells [76]. This evidence concerns the gene TPH1 and irritable bowel syndrome.